Pharmacokinetic analysis of 14C-ursodiol in newborn infants using accelerator mass spectrometry.
Published in the Journal of Clinical Pharmacology 54(9): 1031-1037, 2014.
Quantitative Systems Pharmacology (QSP) informs in vitro to in vivo translation for PCSK9 antibody.
Presented by Rosa at the American Conference on Pharmacometrics (ACoP), 2014
Virtual Systems Pharmacology (ViSP) software for simulation from mechanistic systems-level models
Published in Frontiers of Pharmacology 5: 232, 2014
Physiological modeling offers a valuable tool in early drug development for acne targets
Presented by Stiefel and Rosa at Society for Investigative Dermatology (SID), 2014
Quantitative Systems Pharmacology Modeling to Evaluate Clinical Response of an anti-TNFα/anti-Ang2 Bispecific Antibody in Rheumatoid Arthritis.
Presented by MedImmune and Rosa at the American Society of Clinical Pharmacology and Therapeutics Conference 2014
A population-based approach to systems pharmacology modeling of the effect of blinatumomab (blin) in adult B-precursor ALL patients.
Presented by Amgen and Rosa at American Society for Clinical Pharmacology and Therapeutics (ASCPT), 2014
A Systems Pharmacology Model to Characterize the Effect of Blinatumomab in Patients with Adult B-Precursor Acute Lymphoblastic Leukemia (B-All)
Presented by Amgen and Rosa at the American Society of Clinical Phamacology and Therapeutics Conference, 2014
Applications of Quantitative Systems Pharmacology Modeling to Support Inflammatory Disease Research
Presented by Rosa at the Society for Melanoma Research (SMR), 2014
Application of Quantitative System Pharmacology Modeling to Translational Research
Presented by Rosa at the 19th North American International, 29th Japanese, Society for the Study of Xenobiotics (ISSX/JSSX) meeting, 2014
